Replaces Prod. #: BML-C117
Plant alkaloid. Neurotoxin. Potent acetylcholinesterase inhibitor. Active isomer with acetylcholine esterase activity. Protects cells against hydrogen peroxide, β-amyloid, glutamate, ischemia and staurosporine-induced cytotoxicity and apoptosis. Prospective agent for the treatment of Alzheimer's disease. For the racemic modification, see (±)-Huperzine A (Prod. No. ALX-550-064).
Product Details
| Alternative Name: | (-)-Selagine |
| |
| Formula: | C15H18N2O |
| |
| MW: | 242.3 |
| |
| Source: | Isolated from Lycopodium sp. |
| |
| CAS: | 102518-79-6 |
| |
| MI: | 14: 4755 |
| |
| RTECS: | PB9185700 |
| |
| Purity: | ≥95% |
| |
| Appearance: | White to off-white solid. |
| |
| Solubility: | Soluble in methanol or DMSO. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | +4°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine: R. Wang, et al.; Acta Pharmacol. Sin.
27, 1 (2006), (Review),
Abstract;
Huperzine A, a potential therapeutic agent for treatment of Alzheimer’s disease: D.L. Bai, et al.; Curr. Med. Chem.
7, 355 (2000), (Review),
Abstract;
Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate: H.S. Ved, et al.; Neuroreport
8, 963 (1997),
Abstract;
An Improved Synthetic Route to Huperzine A; New Analogues and Their Inhibition of Acetylcholinesterase: A.P. Kozikowski, et al.; J. C. S. Chem. Commun. 860 (1993),
Natural and synthetic Huperzine A: effect on cholinergic function in vitro and in vivo: I. Hanin, et al.; Ann. N. Y. Acad. Sci.
695, 304 (1993),
Abstract;
Mechanism of inhibition of cholinesterases by huperzine A: Y. Ashani; BBRC
184, 719 (1992),
Abstract;
Potencies and stereoselectivities of enantiomers of huperzine A for inhibition of rat cortical acetylcholinesterase: M. McKinney, et al.; Eur. J. Pharmacol.
203, 303 (1991),
Abstract;
Synthesis and Biological Evaluation of (±)-Z-Huperzine A: A.P. Kozikowski, et al.; Tetrahedron Lett. 31, 6159 (1990),
A Practical Synthesis of the Chinese "Nootropic" Agent Huperzine A: A Possible Lead in the Treatment of Alzheimer's Disease: Y. Xia & A.P. Kozikowski; JACS 111, 4116 (1989),
Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat: X.C. Tang, et al.; J. Neurosci. Res.
24, 276 (1989),
Abstract;
Cholinesterase inhibition by huperzine B: H. Xu & X.C. Tang; Zhongguo Yao Li Xue Bao
8, 18 (1987),
Abstract;
Effects of huperzine A on learning and the retrieval process of discrimination performance in rats: X.C. Tang, et al.; Zhongguo Yao Li Xue Bao
7, 507 (1986),
Abstract;
The effect of the nucleoside transport inhibitor dipyridamole on the incorporation of [3H]thymidine in the rat: J.-S. Liu, et al.; Can. J. Chem. 64, 837 (1986),
Related Products
